EICHOR
● Completed
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
Condition: Diabetes Mellitus, Type 2 · Sponsor: Novo Nordisk A/S
About this study
This study will look at how much CagriSema lowers blood sugar and body weight in people with type 2 diabetes. CagriSema is a new investigational medicine. Doctors cannot yet prescribe CagriSema. CagriSema will be compared to a medicine called tirzepatide. Doctors can prescribe tirzepatide in some countries. Participants will either receive CagriSema or tirzepatide. Which treatment the participant will receive is decided by chance. For each participant, the study will last for up to 1 year and 4 months.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (163)
| Cahaba Research | Pelham, Alabama, United States | — |
| Velocity Clinical Research-Phoenix | Phoenix, Arizona, United States | — |
| AES Tucson DRS | Tucson, Arizona, United States | — |
| Woodland Int. Research Group | Little Rock, Arkansas, United States | — |
| Velocity Clin Res-Chula Vista | Chula Vista, California, United States | — |
| John Muir Physicians Network | Concord, California, United States | — |
| Diabetes & Endocrine Specialists - La Mesa | La Mesa, California, United States | — |
| Velocity Clin Research LA | Los Angeles, California, United States | — |
| Desert Oasis Healthcare | Palm Springs, California, United States | — |
| Velocity Clin Res Santa Ana | Santa Ana, California, United States | — |
| Velocity Clin Res - Panorama | Van Nuys, California, United States | — |
| Optumcare Clinical Trials,LLC-Golden | Colorado Springs, Colorado, United States | — |
+ 151 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06534411